RhumbLine Advisers’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-174,043
Closed -$28.8M 3067
2021
Q2
$28.8M Sell
174,043
-2,571
-1% -$425K 0.04% 434
2021
Q1
$27.1M Sell
176,614
-2,286
-1% -$351K 0.04% 454
2020
Q4
$22.4M Sell
178,900
-4,389
-2% -$551K 0.03% 496
2020
Q3
$18.6M Sell
183,289
-5,325
-3% -$540K 0.03% 498
2020
Q2
$18.4M Buy
188,614
+17,476
+10% +$1.7M 0.03% 480
2020
Q1
$14.2M Sell
171,138
-1,646
-1% -$137K 0.03% 517
2019
Q4
$19.2M Buy
172,784
+1,205
+0.7% +$134K 0.03% 503
2019
Q3
$17M Buy
171,579
+5,737
+3% +$569K 0.03% 514
2019
Q2
$16.4M Buy
165,842
+3,399
+2% +$337K 0.03% 527
2019
Q1
$17.9M Buy
162,443
+2,714
+2% +$299K 0.03% 487
2018
Q4
$14.7M Buy
159,729
+45,356
+40% +$4.17M 0.03% 537
2018
Q3
$12.6M Buy
114,373
+10,080
+10% +$1.11M 0.02% 584
2018
Q2
$9.74M Buy
104,293
+56,791
+120% +$5.3M 0.02% 693
2018
Q1
$3.94M Sell
47,502
-1,691
-3% -$140K 0.01% 1206
2017
Q4
$4.48M Sell
49,193
-7,753
-14% -$706K 0.01% 1135
2017
Q3
$4.34M Buy
56,946
+12,797
+29% +$975K 0.01% 1117
2017
Q2
$3.31M Buy
44,149
+14,413
+48% +$1.08M 0.01% 1253
2017
Q1
$1.94M Buy
29,736
+1,346
+5% +$87.8K ﹤0.01% 1573
2016
Q4
$1.57M Buy
28,390
+1,289
+5% +$71.1K ﹤0.01% 1595
2016
Q3
$1.53M Buy
27,101
+2,238
+9% +$126K ﹤0.01% 1577
2016
Q2
$1.04M Buy
24,863
+3,877
+18% +$162K ﹤0.01% 1764
2016
Q1
$897K Buy
20,986
+260
+1% +$11.1K ﹤0.01% 1864
2015
Q4
$938K Buy
20,726
+2,535
+14% +$115K ﹤0.01% 1847
2015
Q3
$706K Buy
18,191
+556
+3% +$21.6K ﹤0.01% 2004
2015
Q2
$641K Buy
17,635
+1,405
+9% +$51.1K ﹤0.01% 2167
2015
Q1
$468K Buy
+16,230
New +$468K ﹤0.01% 2336